- Home
- ICLR vs MSGS Comparison
ICLR vs MSGS Comparison
Compare ICLR & MSGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ICLR | MSGS |
|---|---|---|
| Founded | 1990 | 1879 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Services-Misc. Amusement & Recreation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.3B | 9.8B |
| IPO Year | 2001 | 2015 |
Fundamental Metrics
Financial Performance| Metric | ICLR | MSGS |
|---|---|---|
| Price | $172.48 | $391.35 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 9 |
| Target Price | $178.62 | ★ $341.29 |
| AVG Volume (30 Days) | ★ 532.6K | 244.3K |
| Earning Date | 05-12-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 134.41 |
| EPS | N/A | ★ 0.32 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.52 |
| P/E Ratio | ★ $12.91 | $1,235.44 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $66.57 | $207.90 |
| 52 Week High | $203.91 | $438.93 |
Technical Indicators
Market Signals| Indicator | ICLR | MSGS |
|---|---|---|
| Relative Strength Index (RSI) | 49.24 | 48.94 |
| Support Level | $162.06 | $379.27 |
| Resistance Level | $183.11 | $397.00 |
| Average True Range (ATR) | 5.66 | 8.74 |
| MACD | -0.90 | -0.60 |
| Stochastic Oscillator | 34.81 | 46.11 |
Price Performance
Historical ComparisonAbout ICLR ICON plc
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.
About MSGS Madison Square Garden Sports Corp. (New)
Madison Square Garden Sports Corp is owns and operates a portfolio of assets featuring some of the recognized teams in all of sports, including the Knicks of the National Basketball Association (NBA) and the Rangers of the National Hockey League (NHL). The company has one operating and reportable segment.